| BASF AG www.basf.com | | Industry Group Code: 325000 | | | | Ranks within this company's industry group: | | Sales: 1 | Profits:2 |
| | | Drugs: | | Discovery: | | | Licensing: | | | Manufacturing: | | | Development: | | | Generics: | | | | |
| | Other: | | AgriBio: | | | Genomics: | | | Proteomics: | | | Tissue Replacement: | | | | | | | |
| | Clinical: | | Trials/Services: | | | Laboratories: | | | Equipment/Supplies: | Y | | Research & Dev. Svcs: | Y | | Diagnostics: | | | |
| | Computers: | | Hardware: | | | Software: | | | Arrays: | | | Database Management: | | | | | |
| | Specialty: | | Specialty Services: | | | Consulting: | | | Blood Collection: | | | Drug Delivery: | | | Drug Distribution: | | | | |
| |
| TYPES OF BUSINESS: | BRANDS/DIVISIONS/AFFILIATES | Chemicals Manufacturing
Agricultural Products
Oil & Gas Production
Plastics
Coatings
Nanotechnology Research
Nutritional Products
Agricultural Biotechnology
|
| Wintershall AG
Orgamol SA
BASF Catalysts LLC
Johnson Polymer
CropDesign
Cehmische Fabrik WIBARCO GmBH
Hansa Chemie International
| | CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. | Jurgen Hambrect, CEO
Kurt W. Bock, CFO
Eggert Voscherau, Dir.-Human Resources
Stefan Marcinowski, Dir.-Research Planning
Kurt W. Bock, Dir.-Info. Svcs.
Stefan Marcinowski, Dir.-Corp. Eng.
Magdalena Moll, Sr. VP-Investor Rel.
Kurt W. Bock, Dir.-Finance
Andreas Kreimeyer, Dir.-Performance Chemicals
John Feldmann, Dir.-Oil & Gas
Stefan Marcinowski, Dir.-Inorganics & Petrochemicals
Peter Oakley, Dir.-Agricultural Prod.
Juergen Hambrecht, Chmn.
Martin Brudermueller, Dir.-APAC
Kurt W. Bock, Dir.-Procurement & Logistics
| | Phone: 49-621-60-0 | | Fax: 49-621-60-42525 | | Toll-Free: N/A | Address: 38 Carl-Bosch St.,
Ludwigshafen 67056 Germany |
| | GROWTH PLANS/SPECIAL FEATURES | BASF is a chemical manufacturing company that operates production facilities in 38 countries, owns 159 subsidiaries and serves customers in more than 170 countries. Around 22% of BASF sales are made to North American industries. BASF operates in five business segments: chemicals; plastics; performance products; agricultural products and nutrition; and oil and gas. The chemicals segment manufactures over 1,500 inorganic, petrochemical and intermediate chemicals for the pharmaceutical, construction, textile and automotive industries. The plastics segment primarily manufactures polystyrene, styrenics and performance polymers for the manufacturing and packaging industries. The performance polymers segment produces pigments, inks, printing supplies, coatings and polymers for the automotive, coatings, oil, paper, packaging, textile, leather, detergent, sanitary care, construction and chemical industries. The firm's agricultural and nutritional products segment produces and markets genetically engineered plants, nutritional supplements, herbicides, fungicides and insecticides for use in agriculture, public health and pest control. Lastly, the oil and gas segment is operated through the BASF subsidiary, Wintershall AG, which focuses on petroleum and natural gas exploration and production in North America, Asia, Europe, the Middle East and Africa. BASF also employs chemical nanotechnology in pigments that are used to color coatings, paints and plastics; aqueous polymer dispersions; and sunscreen. BASF is currently investing over $244 million in the research and development of nanostructured materials, nanostructured surfaces and nanoparticles in hopes of developing nanoporous foams with greater insulating properties and nanocubes as storage mediums for large amounts of gases. BASF discontinued its lysine business in 2007 and shut down its production facility in Gunsan, South Korea. In April 2007, BASF signed an agreement to sell its subsidiary, Cehmische Fabrik WIBARCO GmBH to Hansa Chemie International in Zurich, Switzerland. BASF is one of the world's leading R&D firms, with 8,000 employees working in research in 70 sites worldwide, employing a research budget of $1.3 billion Euros yearly.
BASF offers U.S. employees reimbursement accounts, tuition reimbursement, employee savings plans, adoption assistance and a preferred supplier discount.
|
| FINANCIALS: Sales and profits are in thousands of dollars-add 000 to get the full amount. Yr. 2007 note: Fiscal 2007 results were not available for all companies at press time. For this company, yr. 2007 is for months. | | 2007 Sales: | $84,600,000 | ( months) | 2007 Profits: | $$5,930,000 | ( months) | | 2006 Sales: | $69,448,400 | | 2006 Profits: | $4,575,330 | | | 2005 Sales: | $52,080,500 | | 2005 Profits: | $3,663,700 | | | 2004 Sales: | $51,572,600 | | 2004 Profits: | $2,550,700 | | | 2003 Sales: | $42,575,500 | | 2003 Profits: | $1,144,300 | | Stock Ticker: BF | Employees: 95,175 | Fiscal Year Ends: 12/31 |
| SALARIES/BENEFITS: | | Pension Plan: Y | ESOP Stock Plan: | Profit Sharing: | | Savings Plan: Y | Stock Purch. Plan: Y | | | | | | Top Exec. Salary: Unavailable | Bonus: Unavailable | | Second Exec. Salary: Unavailable | Bonus: Unavailable |
| OTHER THOUGHTS: | LOCATIONS: ('Y' = YES) | | Apparent Top Female Officers: 1 | W | SW | MW | SE | NE | INTER. | | Hot Spots for Advancement for Women/Minorities: | Y | Y | Y | Y | Y | Y |
|